TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today ...
Access Holdings Plc has reported audited results for the financial year ended December 31, 2025, which marks a significant turning ...